Truist Financial
PFE icon

Truist Financial’s Pfizer PFE Stock Holding History

Truist Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$392K – 2794
2021
Q2 		$392K Buy
+10,000
New +$389K ﹤0.01% 2219
2020
Q2 		– Sell
-23,820
Closed -$738K – 2546
2020
Q1 		$738K Buy
+23,820
New +$812K ﹤0.01% 1382

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Truist Financial's PFE Position: Q2 2026 in Review

Truist Financial reduced its Pfizer (PFE) stake by 0.93% in Q2 2026, selling an estimated $601K and leaving 2,447,916 shares worth $58.9M. The position accounts for 0.07% of the portfolio, ranked #224.

Truist Financial first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $283M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Truist Financial held 2,447,916 shares of Pfizer worth $58.9M as of Q2 2026.
  • Truist Financial sold 22,984 Pfizer shares in Q2 2026, an estimated $601K.
  • Pfizer made up 0.07% of Truist Financial's portfolio in Q2 2026, its #224 holding.
  • Truist Financial first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Pfizer position peaked at $283M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.